Logan Lutton

Eli Lilly and Company is acquiring three vaccine companies to expand its reach into infectious disease research and prevention.

Women with high-grade serous ovarian cancer who fasted around chemotherapy sessions had lower insulin levels, improved chemotherapy responses and potentially longer progression-free survival compared with patients who ate normally, according to findings from an Italian study presented at the 2026 American Society of Clinical Oncology Annual Meeting.

In this conversation, Jerome Siegel, Ph.D., professor of psychiatry, David Geffen School of Medicine at UCLA and director of the Center for Sleep Research at the Semel Institute for Neuroscience and Human Behavior at UCLA, explains the findings of his latest study about the neuron damage associated with narcolepsy.

Affordable Care Act Marketplace deductibles hit a record 37% increase in 2026 as expired enhanced tax credits pushed millions of enrollees toward cheaper, higher-deductible bronze plans.

New research suggests that both insufficient and excessive sleep may be linked to faster aging throughout the body and an increased risk of conditions such as depression, diabetes and heart disease.

Young adults with HIV who experience financial instability are significantly more likely to struggle with adhering to antiretroviral therapy, highlighting how economic hardship can directly impact treatment success.

A French study found that a higher dose of ivermectin was not more effective than the standard dose when combined with topical therapy for treating severe scabies.

A pilot study of demodex mites and antimicrobial peptides published in the Journal of the American Academy of Dermatology found biologic differences between sensitive skin syndrome and rosacea, suggesting the conditions are distinct despite sharing similar symptoms and triggers.

A new study published in Cell Reports suggests the transition between wakefulness and sleep involves four distinct mental states, including dream-like thinking that can occur before a person is fully asleep.

Pennsylvania-based UPMC has reached a definitive agreement with CommonSpirit Health to acquire Trinity Health System, expanding its footprint into eastern Ohio.

Meghan Doyle, CEO of Partum Health and Melissa Dennis, OB/GYN and chief medical officer at Partum Health, explain why doulas are an important part of a healthcare team and how Illinois’s Medicaid coverage change was a “catalyst” for their UChicago Medicine partnership.

The Supreme Court has issued an emergency order temporarily preserving nationwide mail prescrption access to the abortion pill mifepristone.

Michael Chancley Jr.’s personal experience with PrEP informs his work at PrEP4All as he advocates for expanded access and equity in HIV prevention amid persistent stigma, provider misinformation and stark racial and gender disparities in PrEP uptake.

Sympathetic nerve fibers within melanoma tumors can slow tumor growth by reducing tumor supportive immune cells, highlighting a potential new target for cancer therapy, according to a new study published in Neuron.

In this clip, Lindsay Greenleaf, J.D., MBA, discusses the latest news concerning the 340B Drug Pricing Program, calling out what she believes is “abuse” within the program.

In this clip, Mike Ciarametaro, managing director of policy at Avalere Health, explains all the “moving pieces” that could affect the health policy landscape in the coming months.

Ahead of Asembia’s 2026 Specialty Pharmacy Summit, Avalere Health's Mina Allo and Mike Ciarametaro discussed the potential impact of PBM reform on the employer market and the likelihood of partisan legislative gridlock ahead of the upcoming elections.

A UC Health system-wide hypertension medication algorithm improved blood pressure control across tens of thousands of patients and was associated with estimated reductions in strokes, heart attacks and deaths.

Skin cells can actively help the rabies virus multiply and pass into nearby nerve cells, explaining how even small bites or scratches, particularly from bats, can lead to infection.

The FDA has approved Merck’s once-daily single-tablet HIV treatment Idvynso (doravirine/islatravir) for virologically suppressed adults, based on phase 3 trials showing high rates of maintained viral suppression and generally manageable safety outcomes.

A study in JAMA Dermatology found that people using an AI tool were more accurate and confident in identifying skin conditions than those using standard methods, though it did not improve their understanding of next steps for care.

The Pharmacy Quality Alliance recognized 10 out of 613 Medicare Part D plans for exceptional or improved medication quality based on Centers for Medicare & Medicaid Services Star Ratings.

Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, explains the evolution of HIV PrEP from daily oral medications to long-acting injectables and how health policy and payer strategies can improve access, adherence and outcomes.

In this interview, Luis Ortiz, M.D., explains the current and emerging therapies for narcolepsy type 1 treatment.

In this interview, Luis Ortiz, M.D., explains how burdensome a narcolepsy diagnosis can be for a patient and why listening to their experiences helps shape new guidelines and treatments.

Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, explains how managed care organizations can support patients at risk of HIV.

Data from an automated refill reminder program identified key patient behaviors and characteristics that strongly predict medication nonadherence, which could enable more targeted interventions by health plans in the future.

From 2023 to 2024, the number of uninsured people in the United States rose for the first time since 2019, mainly because pandemic-era Medicaid protections ended, eligibility checks resumed and many people could not afford or access alternative coverage, according to a new issue brief from KFF.

In this interview, Luis Ortiz, M.D., explains how narcolepsy type 1 is now diagnosed and how it differs from type 2.

A large study of more than 780,000 adolescents found that atopic dermatitis is not associated with lower academic performance on national exams in Denmark or England.